World Health Organization Regional Office for South-East Asia

Challenges facing elimination of Kala azar

                                

*     The wide gap between the number of reported and estimated cases constrains planning of elimination.

*     At present, diagnosis and treatment have been limited to large hospitals. Patients often seek treatment from private doctors or even quacks, who provide expensive, incomplete or inappropriate treatment that favours continued transmission of the disease.

*Currently used drugs like sodium stiboglconate show variable efficacy and are toxic.

*     PKDL patients with only skin signs resulting from delayed or incomplete treatment are reservoirs of infection responsible for continued transmission. These patients are difficult to diagnose and treat.

*     The threat of HIV/AIDS and kala azar co-infection is increasing. If HIV/AIDS epidemic spreads to the general population where kala azar is endemic, it may have disastrous consequences.

 

Back

 

 

||| | ||